openPR Logo
Press release

Intestine Cancer Therapeutics Market 2024 - By Size, Demand, Trends, Top Companies, Growth Drivers And Forecast 2033

04-19-2024 06:54 AM CET | Health & Medicine

Press release from: The Business research company

Intestine Cancer Therapeutics Market

Intestine Cancer Therapeutics Market

The intestine cancer therapeutics market size has grown strongly in recent years. It will grow from $12.8 billion in 2023 to $14 billion in 2024 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to advancements in medical research, increased cancer incidence, chemotherapy and radiation therapies, screening and early detection initiatives, genetic and biomarker discoveries.

The intestine cancer therapeutics market size is expected to see strong growth in the next few years. It will grow to $19.36 billion in 2028 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to immunotherapy advancements, precision medicine and personalized therapies, emerging targeted therapies, integration of artificial intelligence (ai), patient-centric approaches. Major trends in the forecast period include liquid biopsy technologies, precision medicine and biomarker research, combination therapies, patient-centric care and supportive therapies, adoption of minimally invasive surgical techniques.

Market Overview -
Intestine cancer therapeutics refer to the various treatment options available for small intestine and colorectal cancer that affect the digestive system. These treatments aim to remove or manage cancerous cells and improve patient outcomes. The specific treatment plan will depend on the stage of the cancer, the patient's overall health, and other factors.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=13231&type=smp

Rising Prevalence Of Hereditary Colorectal Cancer Syndromes Fuels Growth In Intestine Cancer Therapeutics Market
The increasing prevalence of hereditary colorectal cancer syndromes is expected to propel the growth of the intestine cancer therapeutics market going forward. Hereditary colorectal cancer syndromes are a group of genetic conditions that increase an individual's risk of developing colorectal cancer (colon or rec*tum cancer). Hereditary colorectal cancer syndromes play a significant role in intestinal cancer therapeutics, providing information associated with specific genetic mutations that substantially increase the risk of developing colorectal cancer. For instance, in July 2023, according to the World Health Organization, a Switzerland-based intergovernmental organization, by 2040, the prevalence of hereditary colorectal cancer is projected to increase significantly, with an estimated 3.2 million new cases and 1.6 million deaths annually. This represents a 63% increase in new cases and a 73% increase in fatalities compared to the current rates. Therefore, the increasing prevalence of hereditary colorectal cancer syndromes is driving the growth of the intestine cancer therapeutics market.

Competitive Landscape -
Major companies operating in the intestine cancer therapeutics market report are Pfizer Inc., Johnson & Johnson Private Limited, Roche Holding AG, AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, GSK plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Merck KGaA, Mylan N.V., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Boehringer Ingelheim International GmbH, Sun Pharmaceutical Industries Ltd., Ipsen Pharma, Hikma Pharmaceuticals plc, Amneal Pharmaceuticals LLC, Cipla Inc., Aurobindo Pharma Limited, Lupin Limited

Increasing Focus On Product Approvals To Drive The Revenues
Major companies operating in the intestine cancer therapeutics market are developing innovative products such as Lonsurf and getting approvals to meet larger customer bases, more sales, and increased revenue. LONSURF is a combination of two drugs, trifluridine and tipiracil, for treating adult patients with metastatic colorectal cancer. For instance, in August 2023, Taiho Oncology Inc., a US-based pharmaceutical company, received approval for Lonsurf from the US Food and Drug Administration. Lonsurf is available as a single oral tablet. Trifluridine works by stopping the growth of cancer cells, while tipiracil helps trifluridine to work longer by preventing it from being broken down by the body. The approval of Lonsurf provides patients with metastatic colorectal cancer and other eligible cancers access to a new treatment option that may improve outcomes and quality of life.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/intestine-cancer-therapeutics-global-market-report

Key Segments -
The intestine cancer therapeutics market covered in this report is segmented -
1) By Treatment Type: Immunotherapy, Chemotherapy, Other Treatments
2) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
3) By Application: Hospitals, Homecare, Specialty Centers, Other Applications

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Intestine Cancer Therapeutics Market 2024 - By Size, Demand, Trends, Top Companies, Growth Drivers And Forecast 2033 here

News-ID: 3469403 • Views:

More Releases from The Business research company

Emerging Growth Trends Driving Expansion in the Rocket Exhaust Plume Management Market
Emerging Growth Trends Driving Expansion in the Rocket Exhaust Plume Management …
The rocket exhaust plume management sector is poised for significant expansion as space activities intensify worldwide. Growing demand for efficient and environmentally conscious technologies is driving innovation and investment in this specialized market. The following analysis explores the market size, key players, prevailing trends, and the main segments shaping this industry's future. Forecasted Growth of the Rocket Exhaust Plume Management Market The rocket exhaust plume management market is projected to reach
In-Depth Examination of Segments, Industry Trends, and Key Competitors in the Naval-Based Remote Weapons Station Market
In-Depth Examination of Segments, Industry Trends, and Key Competitors in the Na …
The naval-based remote weapons station market is on track for significant expansion in the coming years, driven by advances in maritime defense technology and evolving naval strategies. As navies worldwide seek to enhance operational efficiency and safety, the demand for sophisticated remote weapon systems is rising steadily. Here's an insightful overview of the market's size, key players, driving factors, notable trends, and segmentation. Projected Market Valuation and Growth Trajectory of the
Top Players and Competitive Dynamics in the Nano UAV Market
Top Players and Competitive Dynamics in the Nano UAV Market
The nano UAV market is on the verge of remarkable expansion, driven by technological advancements and widening applications across various sectors. As these ultra-compact drones evolve, they are set to transform industries such as agriculture, environmental monitoring, and urban surveillance, offering unprecedented precision and efficiency. Let's explore the current market size, influential players, key trends, and significant opportunities shaping the future of this dynamic industry. Forecasted Expansion and Size of the
Overview of Segmentation, Market Dynamics, and Competitive Landscape in the Global Multi-Band GNSS Receiver Market
Overview of Segmentation, Market Dynamics, and Competitive Landscape in the Glob …
The multi-band global navigation satellite system (GNSS) receiver market is poised for significant expansion in the coming years, driven by technological advancements and growing applications across various sectors. As navigation needs become more complex and diverse, the demand for sophisticated GNSS receivers continues to rise, making this a crucial market to watch through 2030. Projected Market Size and Growth of the Multi-Band GNSS Receiver Market The multi-band GNSS receiver market is

All 5 Releases


More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the